Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NYSE:ALB NYSE:CAVA NASDAQ:CELH On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeALBAlbemarle$77.12+1.8%$62.75$49.43▼$113.91$8.91B1.632.93 million shs6.22 million shsCAVACAVA Group$87.49+0.8%$83.74$70.00▼$172.43$10.04B2.653.24 million shs1.97 million shsCELHCelsius$44.430.0%$41.74$21.10▼$51.15$11.46B1.458.08 million shs5.75 million shs7 AI Stocks to Invest in Today: Capitalizing on AI and Tech Trends in 2025Discover the top 7 AI stocks to invest in right now. This exclusive report highlights the companies leading the AI revolution and shaping the future of technology in 2025.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceALBAlbemarle+7.55%+1.86%+26.66%+43.28%-20.32%CAVACAVA Group-2.35%-5.18%+16.37%+1.09%+6.74%CELHCelsius0.00%-1.62%+0.66%+19.36%-12.41%Compare MarketRank™CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & ValuationALBAlbemarle3.9327 of 5 stars3.13.02.50.63.21.70.6CAVACAVA Group3.9346 of 5 stars4.42.00.00.02.62.51.9CELHCelsius2.9432 of 5 stars2.44.00.00.02.32.51.9Compare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceALBAlbemarle 2.11Hold$91.0018.00% UpsideCAVACAVA Group 2.74Moderate Buy$115.0631.51% UpsideCELHCelsius 2.71Moderate Buy$46.474.59% UpsideCurrent Analyst Ratings BreakdownLatest CELH, CAVA, and ALB Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails7/17/2025CAVACAVA GroupBarclaysSubscribe to MarketBeat All Access for the recommendation accuracy ratingBoost Price TargetEqual Weight ➝ Equal Weight$90.00 ➝ $91.007/17/2025CELHCelsiusUBS GroupSubscribe to MarketBeat All Access for the recommendation accuracy ratingBoost Price TargetBuy ➝ Buy$49.00 ➝ $57.007/15/2025ALBAlbemarleMizuhoSubscribe to MarketBeat All Access for the recommendation accuracy ratingSet Price Target$76.007/14/2025ALBAlbemarleWells Fargo & CompanySubscribe to MarketBeat All Access for the recommendation accuracy ratingBoost Price TargetEqual Weight ➝ Equal Weight$60.00 ➝ $75.007/14/2025ALBAlbemarleKeyCorpSubscribe to MarketBeat All Access for the recommendation accuracy ratingLower Price TargetOverweight ➝ Overweight$95.00 ➝ $87.007/14/2025CAVACAVA GroupMorgan StanleySubscribe to MarketBeat All Access for the recommendation accuracy ratingSet Price TargetEqual Weight ➝ Equal Weight$115.00 ➝ $107.007/14/2025CAVACAVA GroupMeliusSubscribe to MarketBeat All Access for the recommendation accuracy ratingInitiated CoverageHold$95.007/14/2025CELHCelsiusTruist FinancialSubscribe to MarketBeat All Access for the recommendation accuracy ratingBoost Price TargetBuy ➝ Buy$50.00 ➝ $55.007/11/2025ALBAlbemarleUBS GroupSubscribe to MarketBeat All Access for the recommendation accuracy ratingSet Price TargetNeutral ➝ Sell$64.00 ➝ $57.007/11/2025ALBAlbemarleUBS GroupSubscribe to MarketBeat All Access for the recommendation accuracy ratingDowngradeNeutral ➝ Sell$64.00 ➝ $57.007/10/2025CELHCelsiusNeedham & Company LLCSubscribe to MarketBeat All Access for the recommendation accuracy ratingBoost Price TargetBuy ➝ Buy$47.00 ➝ $55.00(Data available from 7/18/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)Compare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookALBAlbemarle$5.38B1.69$3.90 per share19.78$67.76 per share1.14CAVACAVA Group$963.71M10.50$0.97 per share89.91$6.07 per share14.41CELHCelsius$1.36B8.45$0.95 per share46.81$1.70 per share26.14Compare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateALBAlbemarle-$1.18B-$11.12N/A40.38N/A-22.39%-1.92%-0.92%7/30/2025 (Estimated)CAVACAVA Group$130.32M$1.20147.07143.434.0913.70%10.61%6.19%8/28/2025 (Estimated)CELHCelsius$145.07M$0.3274.0841.141.588.40%42.12%10.05%8/5/2025 (Estimated)Latest CELH, CAVA, and ALB EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails8/5/2025Q2 2025CELHCelsius$0.23N/AN/AN/A$632.13 millionN/A7/30/2025Q2 2025ALBAlbemarle-$0.76N/AN/AN/A$1.23 billionN/A5/15/2025Q1 2025CAVACAVA Group$0.14$0.22+$0.08$0.22$327.98 million$331.83 million5/6/2025Q1 2025CELHCelsius$0.20$0.18-$0.02$0.15$349.09 million$329.28 million4/30/2025Q1 2025ALBAlbemarle-$0.62-$0.18+$0.44N/A$1.18 billion$1.08 billionCompare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthALBAlbemarle$1.622.10%N/AN/A 30 YearsCAVACAVA GroupN/AN/AN/AN/AN/ACELHCelsiusN/AN/AN/AN/AN/ALatest CELH, CAVA, and ALB DividendsAnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date5/6/2025ALBAlbemarlequarterly$0.40502.82%6/13/20256/13/20257/1/2025(Data available from 1/1/2013 forward)Compare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioALBAlbemarle0.392.111.26CAVACAVA GroupN/A3.002.95CELHCelsiusN/A3.383.04Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipALBAlbemarle92.87%CAVACAVA Group73.15%CELHCelsius60.95%Insider OwnershipCompanyInsider OwnershipALBAlbemarle0.33%CAVACAVA Group6.80%CELHCelsius2.55%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableALBAlbemarle8,300117.66 million117.27 millionOptionableCAVACAVA Group8,100115.66 million107.80 millionOptionableCELHCelsius1,073257.74 million251.17 millionOptionableCELH, CAVA, and ALB HeadlinesRecent News About These CompaniesEdgestream Partners L.P. Acquires Shares of 51,062 Celsius Holdings Inc. (NASDAQ:CELH)July 18 at 5:04 AM | marketbeat.comCelsius Holdings Inc. (NASDAQ:CELH) Given Average Recommendation of "Moderate Buy" by BrokeragesJuly 18 at 2:24 AM | americanbankingnews.comCelsius (NASDAQ:CELH) Price Target Raised to $57.00 at UBS GroupJuly 17 at 10:12 AM | marketbeat.comBallentine Partners LLC Invests $238,000 in Celsius Holdings Inc. (NASDAQ:CELH)July 17 at 4:11 AM | marketbeat.comCelsius Holdings Inc. (NASDAQ:CELH) Shares Sold by Brown Advisory Inc.July 17 at 3:34 AM | marketbeat.comCelsius Holdings Inc. (CELH) Stock Falls Amid Market Uptick: What Investors Need to KnowJuly 16 at 6:46 PM | zacks.comCan Alani Nu's Female-Centric Brand Help CELH Win the Energy Category?July 16 at 10:20 AM | zacks.comCELH Stock Trades at Premium Value: Should You Buy, Hold or Sell?July 15 at 1:10 PM | msn.comCELH Stock Trades at Premium Value: Should You Buy, Hold or Sell?July 15 at 12:31 PM | zacks.comHere is What to Know Beyond Why Celsius Holdings Inc. (CELH) is a Trending StockJuly 15 at 10:00 AM | zacks.comGPM Growth Investors Inc. Invests $1.71 Million in Celsius Holdings Inc. (NASDAQ:CELH)July 15 at 8:15 AM | marketbeat.comSchwarz Dygos Wheeler Investment Advisors LLC Has $1.45 Million Position in Celsius Holdings Inc. (NASDAQ:CELH)July 15 at 7:53 AM | marketbeat.comTeacher Retirement System of Texas Makes New $795,000 Investment in Celsius Holdings Inc. (NASDAQ:CELH)July 15 at 3:21 AM | marketbeat.comCelsius (NASDAQ:CELH) Stock Rating Upgraded by Wall Street ZenJuly 15 at 2:21 AM | americanbankingnews.comCelsius (NASDAQ:CELH) Price Target Raised to $55.00July 14, 2025 | marketbeat.comCelsius Holdings Inc. (NASDAQ:CELH) Shares Purchased by Nisa Investment Advisors LLCJuly 14, 2025 | marketbeat.comDekaBank Deutsche Girozentrale Cuts Position in Celsius Holdings Inc. (NASDAQ:CELH)July 14, 2025 | marketbeat.comBank of New York Mellon Corp Decreases Stock Holdings in Celsius Holdings Inc. (NASDAQ:CELH)July 14, 2025 | marketbeat.comCelsius Holdings Inc. (NASDAQ:CELH) Given Consensus Rating of "Moderate Buy" by AnalystsJuly 13, 2025 | marketbeat.comM&T Bank Corp Has $2.14 Million Stake in Celsius Holdings Inc. (NASDAQ:CELH)July 13, 2025 | marketbeat.comCelsius (NASDAQ:CELH) Upgraded by Wall Street Zen to "Hold" RatingJuly 13, 2025 | marketbeat.comNew MarketBeat Followers Over TimeMedia Sentiment Over TimeTop HeadlinesView All HeadlinesWhy BigBear.ai Could Rally 100% and Catch Palantir SoonBy Gabriel Osorio-Mazilli | June 30, 2025View Why BigBear.ai Could Rally 100% and Catch Palantir Soon3 Defense Leaders Set to Gain From Rising Military SpendBy Chris Markoch | July 5, 2025View 3 Defense Leaders Set to Gain From Rising Military SpendIPO Momentum Returns: 3 Stocks Rising After CoreWeave’s SurgeBy Dan Schmidt | June 20, 2025View IPO Momentum Returns: 3 Stocks Rising After CoreWeave’s SurgeBigBear.ai Poised to Benefit as Palantir Dominates AI DefenseBy Gabriel Osorio-Mazilli | June 23, 2025View BigBear.ai Poised to Benefit as Palantir Dominates AI DefenseCAVA Group: Why the Growth Story Is Just Getting StartedBy Jeffrey Neal Johnson | July 7, 2025View CAVA Group: Why the Growth Story Is Just Getting StartedCELH, CAVA, and ALB Company DescriptionsAlbemarle NYSE:ALB$77.12 +1.38 (+1.82%) Closing price 03:59 PM EasternExtended Trading$77.97 +0.85 (+1.10%) As of 07:59 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Albemarle Corporation develops, manufactures, and markets engineered specialty chemicals worldwide. It operates through three segments: Energy Storage, Specialties and Ketjen. The Energy Storage segment offers lithium compounds, including lithium carbonate, lithium hydroxide, and lithium chloride; technical services for the handling and use of reactive lithium products; and lithium-containing by-products recycling services. The Specialties segment provides bromine-based specialty chemicals, including elemental bromine, alkyl and inorganic bromides, brominated powdered activated carbon, and other bromine fine chemicals; lithium specialties, such as butyllithium and lithium aluminum hydride; develops and manufactures cesium products for the chemical and pharmaceutical industries; and zirconium, barium, and titanium products for pyrotechnical applications that include airbag initiators. The Ketjen segment offers clean fuels technologies (CFT), which is composed of hydroprocessing catalysts (HPC) together with isomerization and akylation catalysts; fluidized catalytic cracking (FCC) catalysts and additives; and performance catalyst solutions (PCS), which is composed of organometallics and curatives. The company serves the energy storage, petroleum refining, consumer electronics, construction, automotive, lubricants, pharmaceuticals, and crop protection markets. Albemarle Corporation was founded in 1887 and is headquartered in Charlotte, North Carolina.CAVA Group NYSE:CAVA$87.49 +0.72 (+0.83%) Closing price 03:59 PM EasternExtended Trading$87.26 -0.23 (-0.27%) As of 07:58 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.CAVA Group, Inc. owns and operates a chain of restaurants under the CAVA brand in the United States. The company also offers dips, spreads, and dressings through grocery stores. In addition, the company provides online and mobile ordering platforms. Cava Group, Inc. was founded in 2006 and is headquartered in Washington, the District of Columbia.Celsius NASDAQ:CELH$44.43 -0.02 (-0.04%) Closing price 04:00 PM EasternExtended Trading$44.42 -0.02 (-0.03%) As of 07:59 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Celsius Holdings, Inc. develops, processes, markets, distributes, and sells functional energy drinks and liquid supplements in the United States, Australia, New Zealand, Canadian, European, Middle Eastern, Asia-Pacific, and internationally. The company offers CELSIUS, a fitness drink or supplement designed to accelerate metabolism and burn body fat; various flavors and carbonated and non-carbonated functional energy drinks under the CELSIUS Originals and Vibe name, as well as functional energy drink under the CELSIUS Essentials and CELSIUS On-the-Go Powder names; and CELSIUS ready-to drink products. It distributes its products through direct-to-store delivery, distributors, supermarkets, convenience stores, drug stores, nutritional stores, and mass merchants, as well as health clubs, gyms, the military, and e-commerce websites. The company was formerly known as Vector Ventures, Inc. and changed its name to Celsius Holdings, Inc. in January 2007. Celsius Holdings, Inc. was founded in 2004 and is headquartered in Boca Raton, Florida. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30DroneEcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerFlying CarGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMade In AmericaMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSocial MediaSolarSpaceTechnologyTelecomToyUraniumUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas Netflix Q2 2025 Earnings: What Investors Need to Know High-Flying GE Aerospace Drops After Blowout Q2 — What Now? A New $70 Billion AI Investment Could Push Taiwan Semiconductor Why Prologis May Be the Smartest Backdoor Bet on AI Real Estate Snap-On: Snap Up This Strong Signal While It’s Still Cheap Why Abbott Laboratories Is a Q2 2025 Buy: Growth & Yield Why Pure Storage Is a Core Investment for the AI Era How Goldman Sachs Earnings Help You Strategize Your Portfolio Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
